Specialty Chemicals company Fineotex Chemical announced Q1FY26 results Revenue from Operation for the Quarter has increased to ~ Rs 13,707 lakh from ~Rs 11,979 lakh i.e., a growth of ~ 14.43%. Profit after tax (PAT) for the quarter ended has increased to ~Rs 2,503 lakh from ~Rs 2,013 lakh i.e., a growth of ~ 24.34%. Operational EBITDA for the quarter has increased to ~Rs 2,520 lakh from ~Rs 2,129 lakh i.e., a growth of ~ 18.37%. Result PDF
Conference Call with Fineotex Chemical Management and Analysts on Q4FY25 & Full Year Performance and Outlook. Listen to the full earnings transcript.
Specialty Chemicals company Fineotex Chemical announced Q4FY25 & FY25 results Consolidated Q4FY25 Financial Highlights: Revenue from Operation for the quarter is Rs 11,978.54 Lakh Profit after tax (PAT) for the quarter ended is Rs 2,013.13 Lakh Gross Margin for the Quarter ended is 36.22% PAT Margin for the Quarter ended is 16.81% Consolidated FY25 Financial Highlights: Revenue from Operation is Rs 53,333.28 Lakh Profit after tax (PAT) for the year ended is Rs 10,920.82 Lakh. Gross Margin for the year ended is 38.57% PAT Margin for the year ended is 20.48% Standalone Q4FY25 Financial Highlights: Revenue from Operation for the year is Rs 43,922.21 Lakh Profit after tax (PAT) for the year ended is Rs 9,722.67 Lakh Gross Margin for the Quarter ended is 38.24% PAT Margin for the Quarter ended is 22.14% Standalone FY25 Financial Highlights: Revenue from Operation for the quarter is Rs 10,794.60 Lakh Profit after tax (PAT) for the quarter ended is Rs 1,944.05 Lakh Gross Margin for the Quarter ended is 35.30% PAT Margin for the Quarter ended is 18.01% Commenting on the overall performance of the Company, Sanjay Tibrewala, Executive Director, Fineotex Chemical said, “We ended FY25 on a stable footing, with steady performance in the textile chemicals segment and strong growth in newly diversified businesses. Despite a nuanced demand environment, our strategic direction remains clear, and we continue to execute with resilience and a long-term growth mindset. During the quarter, the textile chemicals segment remained stable, with sustained demand across key geographies. We added 30 new customers during fourth quarter, a testament to our expanding reach and trusted product performance. We also developed 15 new products, reinforcing our focus on innovation and our ability to respond swiftly to evolving customer requirements. While the FMCG, Cleaning & Hygiene segment witnessed a temporary softness in volumes, the underlying demand fundamentals remain intact, and we anticipate a pickup in the coming quarters.. Our new business verticals — Water Treatment and Oil & Gas — delivered strong performance, with a substantial increase in both volumes and value contribution backed by a robust and growing order pipeline. Further, we are undertaking focused capital expenditure, promotional and brand-building initiatives. These investments are aimed at enhancing production capabilities, strengthening market presence, and accelerating customer acquisition in these fast-growing business segments. These business lines are expected to play an increasingly significant role in our revenue mix in the coming years A major milestone during the year was the government approval of AquaStrike Premium, our biotechnology based mosquito control solution developed using Azadirachtin. This plant-based, sustainable innovation opens up growth opportunities in public health and institutional hygiene, both in India and emerging markets. Looking ahead, we are optimistic about the export environment. The India–UK Free Trade Agreement, is expected to improve market access, reduce trade barriers, and enhance our competitiveness in the UK and Europe, particularly for textile and specialty chemicals. To support our growth aspirations, we are pleased to report that our greenfield expansion is progressing as planned and will add 15,000 MTPA of capacity, increasing our total installed capacity to 1,20,000 MTPA expected to commence operations in Q2FY26. With a diversified product portfolio, strong demand pipeline, growing international reach, and a healthy balance sheet, we remain confident in our strategic roadmap and we are well-positioned to deliver consistent, long-term value to all stakeholders.” Result PDF
Conference Call with Fineotex Chemical Management and Analysts on Q3FY25 Performance and Outlook. Listen to the full earnings transcript.
Specialty Chemicals company Fineotex Chemical announced Q3FY25 results Total Income was Rs 130.91 crore in Q3FY25 compared to Rs 143.39 crore in Q3FY24, a slight decline of 9%. The decline in revenue was on account of muted demand in FMCG, one of the key sectors that Company caters to. Operating EBITDA (excluding other income) stood at Rs 34.29 in Q3FY25. Operating EBITDA Margin was 27.2% in Q3FY25. PAT stood at Rs 27.83 crore in Q3FY25. Sanjay Tibrewala, Executive Director, Fineotex Chemical, said: “The Company’s performance for the nine months of FY25 remained stable despite a challenging environment with muted demand in the FMCG space, one of the key sectors that we cater to. Our guidance for revenue and profitability is intact. Revenue for the quarter was impacted by low volumes due to order postponements by a few customers. However, there has been no loss of customers, as demand fundamentals remain strong. While the FMCG segment experienced lesser demand in the quarter, which we foresee to boost in the forthcoming quarter, the textiles vertical is doing well. In fact in the textiles business, we added 30 new customers in Q3FY25. As India’s long-term growth trajectory remains intact with growth oriented budget and liquidly boosting by RBI, we are confident of our targets. Our diversification into new products, such as oil & gas and water treatment, is progressing well, with a strong order pipeline expanding across geographies. Additionally, our upcoming plant remains on track and is expected to be operational by Q2FY26, further enhancing our manufacturing capabilities. With innovation at the core of our business, new solutions like AquaStrike Premium reinforce our commitment to sustainability and global market expansion. During the quarter, we developed 15 new products increasing our product offerings. We remain committed to creating long-term value and will be issuing a dividend, reflecting our confidence in the company’s financial health. We see this slackness as an opportunity to grab the good targets for our inorganic growth opportunities, with our earmarked cash funds of more than Rs 300 crore. The outlook remains positive, our revenue and profitability guidance are intact.” Result PDF
Specialty Chemicals company Fineotex Chemical announced H1FY25 & Q2FY25 results Q2FY25 Financial Highlights: Standalone: Revenue from Operation for the Quarter has increased to ~ Rs 11,536 lakh from ~ Rs 10,661 lakh i.e., a growth of 8.21% QoQ. The Profit after tax (PAT) has increased to ~Rs. 3,145 lakh from ~ Rs 2,185 lakh i.e., a growth of 43.94% QoQ. The Operational EBITDA has increased to ~Rs. 2,971 lakh from ~Rs. 2,618 lakh i.e., a growth of 13.48% QoQ. Consolidated: Revenue from Operation for the Quarter has increased to ~ Rs 14,573 lakh from ~ Rs 14,190 lakh i.e., a growth of 2.70% QoQ. The Profit after tax (PAT) has increased to ~Rs. 3,207 lakh from ~ Rs 2,918 lakh i.e., a growth of 9.90% QoQ. H1FY25 Financial Highlights: Standalone: Revenue from Operation for the half year has increased to ~ Rs 22,197 lakh from ~ Rs 19,253 lakh i.e., a growth of 15.29% YoY. The Profit after tax (PAT) has increased to ~Rs. 5,330 lakh from ~ Rs 5,000 lakh i.e., a growth of 6.60% YoY. The Operational EBITDA has increased to ~Rs. 5,589 lakh from ~Rs. 5,022 lakh i.e., a growth of 11.29% YoY. Consolidated: Revenue from Operation for the half year has increased to ~ Rs 28,763 lakh from ~ Rs 27,750 lakh i.e., a growth of 3.65% YoY. The Profit after tax (PAT) has increased to ~Rs. 6,125 lakh from ~ Rs 5,762 lakh i.e., a growth of 6.30% YoY. Other Highlights: We have completed successful fund raise of Rs 218.11 crore through Preferential Allotment of Equity Shares and Convertible Warrants at a price of Rs 387.40/- with a total fund raise of Rs 342.55/- crore during this financial year upto 30th September 2024. The Nomination and Remuneration Committee at its meeting held on November 13, 2024, has considered and approved the Allotment of 25,052 Equity Shares pursuant to exercise of vested Employee Stock Options under the Fineotex Chemical Limited - Employee Stock Option Plan 2020 ("FCL-ESOP 2020”). The company has granted an ESOP to 110 Employees upto 30th September 2024. Result PDF